Onderneming Virpax Pharmaceuticals, Inc.
Aandelen
VRPX
US9282512063
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,24 USD | +0,45% | -27,74% | -30,02% |
Vakgebied
Aantal werknemers: 7
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jeffrey Gudin
FOU | Founder | 58 | 01-01-17 |
Gerald Bruce
CEO | Chief Executive Officer | 68 | 01-08-17 |
Vinay Shah
DFI | Director of Finance/CFO | 62 | 20-06-23 |
Chief Tech/Sci/R&D Officer | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gerald Bruce
CEO | Chief Executive Officer | 68 | 01-08-17 |
Jeffrey Gudin
FOU | Founder | 58 | 01-01-17 |
Director/Board Member | - | 24-03-23 | |
Eric Floyd
CHM | Chairman | 62 | 01-01-17 |
Jerrold Sendrow
BRD | Director/Board Member | 79 | 01-01-17 |
Vanila Singh
BRD | Director/Board Member | 53 | 01-06-20 |
Director/Board Member | 60 | 01-01-17 | |
Michael Dubin
BRD | Director/Board Member | 68 | 26-07-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 171 233 | 869 973 ( 74,28 %) | 0 | 74,28 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-30,02% | 2,62 mln. | |
+25,69% | 47,9 mld. | |
+46,90% | 41,42 mld. | |
-3,46% | 40,7 mld. | |
-6,20% | 28,92 mld. | |
+9,17% | 25,55 mld. | |
-20,42% | 19,27 mld. | |
+0,17% | 12,15 mld. | |
+28,07% | 12,14 mld. | |
-1,24% | 11,99 mld. |
- Beurs
- Aandelen
- Koers VRPX
- Onderneming Virpax Pharmaceuticals, Inc.